To lessen bruising, do not rub the injection site after each dose. Learn how to store and discard medical supplies safely. Patients who are getting immune globulin for the first time, those who ...

HYQVIA is the first plasma-derived therapy for subcutaneous injection in Japan that consists of a combination of one vial of Immunoglobulin 10% and one vial of Recombinant Human Hyaluronidase PH20 ...

but subcutaneous immunoglobulin bypasses this issue. The CSL-sponsored trial also uses a control injection of the same volume to ensure accuracy, she said. Animal studies from Iwasaki’s lab have ...

"We are very pleased that patients in Japan with agammaglobulinemia or hypogammaglobulinemia can now access HYQVIA, which represents the first and only subcutaneous immunoglobulin therapy that ...

A drug targeting immunoglobulin G (IgG) currently approved for myasthenia gravis and chronic inflammatory demyelinating ...

The treatment, a weekly 30-to-90 second subcutaneous injection, is the first neonatal Fc receptor (FcRn) blocker approved for CIDP. It works by decreasing the recycling of immunoglobulin G (IgG ...

Education before subcutaneous daratumumab administration can both reassure patients and reduce the occurrence of adverse ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant ...